ORIC Return on Tangible Equity | ORIC PHARMACEUTICALS, INC.

ORIC PHARMACEUTICALS, INC. (ORIC) Return on Tangible Equity

2026-06-30: Return Tang Equity -36.81%.
2026-03-31: Return Tang Equity -32.54%.
2025-12-31: Return Tang Equity -33.68%.
2025-09-30: Return Tang Equity -33.24%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-36.81%
2026-03-31	-32.54%
2025-12-31	-33.68%
2025-09-30	-33.24%
2025-06-30	-42.36%
2025-03-31	-60.46%
2024-12-31	-52.59%
2024-09-30	-43.75%
2024-06-30	-36.63%
2024-03-31	-30.96%
2023-12-31	-44.94%
2023-09-30	-37.68%
2023-06-30	-34.44%
2023-03-31	-44.33%
2022-12-31	-40.08%
2022-09-30	-42.38%
2022-06-30	-35.73%
2022-03-31	-33.73%
2021-12-31	-28.84%
2021-09-30	-28.88%
2021-06-30	-35.35%
2021-03-31	-29.46%
2020-12-31	-25.43%
2020-09-30	-29.18%
2020-06-30	-17.82%
2020-03-31	30.22%
2019-12-31	29.84%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-33.68%
2024-12-31	-52.59%
2023-12-31	-44.94%
2022-12-31	-40.08%
2021-12-31	-28.84%
2020-12-31	-25.43%
2019-12-31	29.84%
2018-12-31	33.16%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Kardigan, Inc. (KARD)	United States	$1.346B
Tyra Biosciences, Inc. (TYRA)	United States	$1.337B	-12.83
Bicara Therapeutics Inc. (BCAX)	United States	$1.309B	-10.55
First Tracks Biotherapeutics, Inc. (TRAX)	United States	$1.280B
OMEROS CORP (OMER)	United States	$1.456B	5.50
Ultragenyx Pharmaceutical Inc. (RARE)	United States	$1.456B	-5.62
Avalyn Pharma Inc. (AVLN)	United States	$1.267B
Damora Therapeutics, Inc. (DMRA)		$1.250B	-6.10
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Innoviva, Inc. (INVA)	United States	$1.493B	4.62